PTGS2 and atherosclerosis: In the present study, the effective components, potential therapeutic targets, and therapeutic pathways of XFZYD for ASCVD were described, and the therapeutic mechanism of quercetin and therapeutic targets PTGS2 on human umbilical vein endothelial cells (HUVECs) were verified in vitro.